Image_1_Tumor-Derived Autophagosomes (DRibbles) Activate Human B Cells to Induce Efficient Antigen-Specific Human Memory T-Cell Responses.jpeg
We have reported that tumor-derived autophagosomes (DRibbles) were efficient carriers of tumor antigens and DRibbles antigens could be present by DRibbles-activated B cells to stimulate effect and naïve T cells in mice. However, the effect of DRibbles on human B cells remains unclear. Herein, we found that DRibbles can also efficiently induce proliferation and activation of human B cells and lead to the production of chemokines, cytokines and hematopoietic growth factors. We further demonstrated human B cells can effectively phagocytose DRibbles directly and cross-present DRibbles antigens to stimulate antigen-specific memory T cells. Furthermore, we found that membrane-bound high-mobility group B1 (HMGB1) on DRibbles was crucial for inducing human B cells activation. Therefore, these findings provide further evidence to promote the clinical application of B-DRibbles vaccines.
History
References
- https://doi.org//10.1038/nature11910
- https://doi.org//10.3390/cancers13051039
- https://doi.org//10.1038/s41556-019-0450-y
- https://doi.org//10.1016/j.semcdb.2015.02.009
- https://doi.org//10.1146/annurev-immunol-041015-055700
- https://doi.org//10.1158/1078-0432.CCR-11-0951
- https://doi.org//10.4161/auto.5.4.8366
- https://doi.org//10.1158/0008-5472.CAN-08-0161
- https://doi.org//10.1158/1078-0432.CCR-11-0812
- https://doi.org//10.1186/1479-5876-12-100
- https://doi.org//10.4049/jimmunol.1502193
- https://doi.org//10.1111/j.1365-2249.2008.03820.x
- https://doi.org//10.1371/journal.pone.0013016
- https://doi.org//10.1371/journal.pone.0053564
- https://doi.org//10.1097/CJI.0000000000000051
- https://doi.org//10.1007/s00262-020-02695-5
- https://doi.org//10.1186/s12967-014-0361-4
- https://doi.org//10.1093/toxsci/kfu257
- https://doi.org//10.1186/s13075-020-02372-z
- https://doi.org//10.1007/s10875-010-9456-8
- https://doi.org//10.1007/s10875-010-9507-1
- https://doi.org//10.1016/j.cellimm.2019.103987
- https://doi.org//10.4049/jimmunol.0902551
- https://doi.org//10.1084/jem.192.2.205
- https://doi.org//10.1089/jmf.2013.2912
- https://doi.org//10.1007/s10787-015-0256-x
- https://doi.org//10.1007/978-3-030-36667-4_2
- https://doi.org//10.1002/jcb.27049
- https://doi.org//10.1189/jlb.0803379
- https://doi.org//10.1016/j.autrev.2008.12.002
- https://doi.org//10.4049/jimmunol.168.7.3195
- https://doi.org//10.1038/nrrheum.2009.178
- https://doi.org//10.2147/ITT.S262566
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity